Filed before 2025Filed 6 October 2016
Lysosomal Therapeutics, Inc. raised $6M
Lysosomal Therapeutics, Inc., a biotech company based in Cambridge, MA, raised $6M in a new debt round, according to a filing dated 6 October 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 6 October 2016
- Round
- Debt round
- Amount sold
- $6M
- Offering size
- $6M
- Investors so far
- 9
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 54% of the 1,506 tracked raises with an amount filed in 2016, and than 51% of the 120 in biotech.
Lysosomal Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 7 Nov 2019 | New filing | $1M | Another raise |
| 18 Jan 2017 | Amended filing | $26.1M | Another raise |
| 6 Oct 2016 | New filing | $6M | This raise |
| 11 Feb 2015 | New filing | $10M | Another raise |
More with Atlas on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.